GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM5117
Query DataSets for GSM5117
Status
Public on Jun 25, 2003
Title
Isoflurane 5 exposures-1
Sample type
RNA
Source name
WHOLE BRAIN
Organism
Rattus norvegicus
Extracted molecule
total RNA
Description
Two 90 minute exposures (3 hr recovery in between) to 1.0% isoflurane every day for 2.5 days, for a total of 5 exposures
Keywords = Eckenhoff, anesthetics
Submission date
Mar 25, 2003
Last update date
Mar 17, 2006
Contact name
Roderic Eckenhoff
E-mail(s)
[email protected]
Phone
215-662-3705
Organization name
University of Pennsylvania
Department
Street address
City
Philadelphia
State/province
PA
ZIP/Postal code
19104
Country
USA
Platform ID
GPL85
Series (3)
GSE358
Isoflurane Repetitive Exposure
GSE752
Halothane/Isoflurane Repetitive Exposures
GSE6433
Halothane/Isoflurane repetitive exposures
Data table header descriptions
ID_REF
VALUE
Affy MAS5.0 Signal
ABS_CALL
Affy MAS5.0 Detection call
QUALITY
Affy MAS5.0 Detection p-value
Data table
ID_REF
VALUE
ABS_CALL
QUALITY
AFFX-MurIL2_at
7.5
A
0.724854
AFFX-MurIL10_at
6.8
A
0.672921
AFFX-MurIL4_at
3.3
A
0.772364
AFFX-MurFAS_at
5
A
0.772364
AFFX-BioB-5_at
128
A
0.139482
AFFX-BioB-M_at
85.4
P
0.006871
AFFX-BioB-3_at
49.7
A
0.116113
AFFX-BioC-5_at
327.7
P
0.001248
AFFX-BioC-3_at
153
P
0.006187
AFFX-BioDn-5_at
264.1
P
0.001796
AFFX-BioDn-3_at
1910.2
P
0.000509
AFFX-CreX-5_at
2470
P
0.000044
AFFX-CreX-3_at
3877
P
0.000044
AFFX-BioB-5_st
33.6
A
0.287743
AFFX-BioB-M_st
37
A
0.617401
AFFX-BioB-3_st
13.4
A
0.910522
AFFX-BioC-5_st
9.2
A
0.932322
AFFX-BioC-3_st
10.1
A
0.876428
AFFX-BioDn-5_st
15.2
A
0.455413
AFFX-BioDn-3_st
18.5
A
0.327079
Total number of rows:
8799
Table truncated, full table size
250 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|